An international journalism investigation of the medical device industry describes dangerous devices, kickbacks to doctors and weak regulations – and shines a spotlight on a medical company with a big presence in Memphis.
A quick look at the story of Infuse, the controversial medical treatment marketed by the Memphis-based spinal unit of Medtronic.
Daniel Connolly, The Commercial Appeal
That company is Medtronic, which has its main operations in Minneapolis and annual sales of about $30 billion.
One of its units, Medtronic Spine, is based in Memphis and employs some 1,500 people here.
Medtronic Spine sells a product called Infuse that promotes bone growth. The government